• Fighting for Patient Access, Affordability, and Transparency in Health Care
Patients Rising Now
  • About
    • Corporate Membership
    • Current Corporate Members
  • Issues
    • News and Insights
    • Position Statements
    • Policy Supported
  • Advocacy Master Class
  • Get Involved
  • Donate
Select Page
  • About
    • Corporate Membership
    • Current Corporate Members
  • Issues
    • News and Insights
    • Position Statements
    • Policy Supported
  • Advocacy Master Class
  • Get Involved
  • Donate
Trump administration proposes insurance loophole to hike patient out-of-pocket costs in 2021

Trump administration proposes insurance loophole to hike patient out-of-pocket costs in 2021

Feb 22, 2020 | Copay Accumulators, Copay Assistance, Drug Costs, Federal Issues, News

Patients struggling with the high cost of health insurance can expect even higher out-of-pocket costs in 2021, under an insurance regulation proposed by the Centers for Medicare & Medicaid Services. Last month, the obscure federal agency under the Department of...
New CMS co-pay rule will increase out-of-pocket costs in 2020

New CMS co-pay rule will increase out-of-pocket costs in 2020

Sep 9, 2019 | Copay Accumulators, Drug Costs, News, Out of Pocket Costs

Get ready for higher out-of-pocket costs in 2020. Last week, the Trump administration’s Centers for Medicare & Medicaid Services quietly announced new co-pay rules that will allow insurance companies to increase patients’ out-of-pocket costs in 2020....

Categories

  • Actions
  • Copay Accumulators
  • Copay Assistance
  • COVID-19
  • Drug Costs
  • Featured
  • Federal Issues
  • Health Insurance
  • Health Policy
  • ICER
  • Issues
  • Letters Submitted
  • Letters Supported
  • Medicaid
  • Medicare
  • Medicare Part D
  • News
  • Op-Ed
  • Out of Pocket Costs
  • Pharmacy Benefit Managers
  • Podcast
  • QALY
  • State Issues
  • Step Therapy
  • Uncategorized
  • Value Frameworks

Tags

340B Biden Administration Cancer chemo drugs cms Copay Accumulators copay assistance deferred action DPC drug costs drug discount programs Drug Importation Drug Manufacturing Drug Pricing drug rebate Elizabeth Warren fail first Health Insurance hospital bills HR 3708 hsa ICER immigration Imported Drugs Insurance design Joe Biden Medicaid medicare Part B medicare part D Nonmedical Switching open enrollment out of Out of Pocket Costs Patient Access Patients Assitance PBM pharmacy pharmacy benefit managers Preexisting Conditions Price Transparency Prior Authorization QALY Step Therapy transparency Value Framework

Recent Posts

  • S2 | E2: Mystery Hospital Costs 
  • S2 | E1: Will Democrats Help or Hurt Patients?
  • Episode 45: Pro-Patient Agenda Revealed
  • Episode 44: Patients Hurt by Most Favored Nation Rule
  • Episode 43: Navigating Legal Hurdles

Patients Rising Now

We are a 501c4 group dedicated to demanding transparency in health care.

Patients Rising Now

11710 Plaza America Drive
Suite 200
Reston, VA 20109
  • Privacy Policy
  • Sponsor Opportunities
  • Facebook
  • Twitter
  • Instagram
All rights reserved. © 2021 Patients Rising Now